Holdings of PROFUND VP PHARMACEUTICALS ProFunds
· 59 declared positions · as of Mar 31, 2026
Original filing · Net assets 10.2M $ · Ten largest lines: 20.9 % of the equity sleeve
Sector breakdown Health care 9.6 % Unattributed 90.4 % Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown US 93.0 % IE 4.1 % CA 1.9 % SG 1.0 % Shares computed on the equity sleeve, the only part this site carries.
Country Lines Value Share US 55 9.1M $ 93.01 % IE 2 396K $ 4.06 % CA 1 190K $ 1.95 % SG 1 96.4K $ 0.99 %
Positions Company Shares Value Weight Enliven Therapeutics Inc 6,101 239.2K $ 2.35 % Corcept Therapeutics Inc 5,551 223.8K $ 2.20 % Terns Pharmaceuticals Inc 4,004 211.1K $ 2.08 % Perrigo Co PLC 19,092 205K $ 2.02 % Axsome Therapeutics Inc 1,174 198.4K $ 1.95 % Innoviva Inc 8,354 194.6K $ 1.91 % Merck & Co Inc 1,612 193.9K $ 1.91 % Pfizer Inc 6,860 192.6K $ 1.89 % Royalty Pharma PLC 4,011 192.4K $ 1.89 % Elanco Animal Health Inc 7,987 191.1K $ 1.88 % Jazz Pharmaceuticals PLC 1,010 190.9K $ 1.88 % Esperion Therapeutics Inc 69,630 190.8K $ 1.88 % Edgewise Therapeutics Inc 6,043 190.4K $ 1.87 % MBX Biosciences Inc 6,369 190.1K $ 1.87 % Definium Therapeutics Inc 10,053 190K $ 1.87 % Bristol-Myers Squibb Co 3,123 189.4K $ 1.86 % ANI Pharmaceuticals Inc 2,455 188.8K $ 1.86 % Johnson & Johnson 771 188.5K $ 1.85 % Tarsus Pharmaceuticals Inc 2,680 188K $ 1.85 % Trevi Therapeutics Inc 15,686 187.1K $ 1.84 % Pacira BioSciences Inc 8,204 185.4K $ 1.82 % Zoetis Inc 1,563 184.8K $ 1.82 % Crinetics Pharmaceuticals Inc 5,065 184K $ 1.81 % Nektar Therapeutics 2,554 183.8K $ 1.81 % Liquidia Corp 4,857 183.3K $ 1.80 % Amneal Pharmaceuticals Inc 14,735 183.2K $ 1.80 % Harmony Biosciences Holdings Inc 6,505 182.2K $ 1.79 % Supernus Pharmaceuticals Inc 3,519 181.9K $ 1.79 % Viatris Inc 13,406 181.1K $ 1.78 % Xeris Biopharma Holdings Inc 30,952 179.5K $ 1.77 % Harrow Inc 5,070 178.8K $ 1.76 % Organon & Co 29,264 175.3K $ 1.72 % Nuvation Bio Inc 40,803 175K $ 1.72 % Phibro Animal Health Corp 3,161 174.8K $ 1.72 % Amylyx Pharmaceuticals Inc 12,544 174.4K $ 1.71 % Indivior Pharmaceuticals Inc 5,705 173.9K $ 1.71 % Collegium Pharmaceutical Inc 5,258 173.9K $ 1.71 % Eli Lilly & Co 187 172K $ 1.69 % Prestige Consumer Healthcare Inc 2,890 171.3K $ 1.68 % Ligand Pharmaceuticals Inc 847 169.1K $ 1.66 % Ocular Therapeutix Inc 19,715 167K $ 1.64 % Omeros Corp 15,699 165.8K $ 1.63 % EyePoint Inc 12,553 161.8K $ 1.59 % Alumis Inc 7,110 156.6K $ 1.54 % Amphastar Pharmaceuticals Inc 7,223 141.5K $ 1.39 % Phathom Pharmaceuticals Inc 12,655 140.6K $ 1.38 % Theravance Biopharma Inc 8,528 138.4K $ 1.36 % Rapport Therapeutics Inc 4,267 133.5K $ 1.31 % Arvinas Inc 11,487 121.8K $ 1.20 % CorMedix Inc 17,585 119.4K $ 1.17 % BioAge Labs Inc 6,693 117.1K $ 1.15 % Maze Therapeutics Inc 3,713 110.8K $ 1.09 % Septerna Inc 4,081 98.1K $ 0.96 % WaVe Life Sciences Ltd 13,302 96.4K $ 0.95 % Zevra Therapeutics Inc 10,307 96.1K $ 0.94 % Fulcrum Therapeutics Inc 11,666 89.5K $ 0.88 % Aquestive Therapeutics Inc 19,045 79K $ 0.78 % LB Pharmaceuticals Inc 2,830 69.8K $ 0.69 % Alto Neuroscience Inc 2,325 52.3K $ 0.51 %